微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 23.56% | -36.9% | -19.47% | 129/157 | 50.55% | 泽璟制药 | 94.64% | 行业排名> |
| 2025-12-31 | 29.25% | -19.61% | -10.82% | 118/157 | 50.61% | 海创药业 | 99.82% | 行业排名> |
| 2025-09-30 | 32.8% | -8.43% | -8.55% | 111/157 | -2.2% | 海创药业 | 98.62% | 行业排名> |
| 2025-06-30 | 35.87% | 1.57% | -3.93% | 105/157 | 14.83% | 海创药业 | 99.57% | 行业排名> |
| 2025-03-31 | 37.33% | 8.47% | 2.6% | 97/157 | 31.96% | 海创药业 | 99.52% | 行业排名> |
| 2024-12-31 | 36.39% | 15.24% | 1.58% | 105/157 | 51.88% | 艾力斯 | 96.74% | 行业排名> |
| 2024-09-30 | 35.82% | 19.67% | 1.44% | 105/157 | 22.51% | 首药控股 | 98.96% | 行业排名> |
| 2024-06-30 | 35.31% | 24.36% | 2.59% | 108/157 | 33.12% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-03-31 | 34.42% | 31.59% | 9.01% | 108/157 | 51.76% | 百利天恒 | 97.99% | 行业排名> |
| 2023-12-31 | 31.57% | 27.33% | 5.48% | 118/157 | 51.61% | 百利天恒 | 98.92% | 行业排名> |
| 2023-09-30 | 29.93% | 5.97% | 5.42% | 119/157 | 32.47% | 迈威生物 | 98.93% | 行业排名> |
| 2023-06-30 | 28.4% | -0.54% | 8.56% | 122/157 | 38.42% | 迈威生物 | 99.59% | 行业排名> |
| 2023-03-31 | 26.16% | 13.73% | 5.48% | 124/157 | 52.97% | 迈威生物 | 99.8% | 行业排名> |
| 2022-12-31 | 24.8% | 11.64% | -12.21% | 130/157 | 53.83% | 迈威生物 | 99.46% | 行业排名> |
| 2022-09-30 | 28.25% | 15.47% | -1.06% | 119/157 | 5.64% | 迈威生物 | 99.75% | 行业排名> |
| 2022-06-30 | 28.55% | 2% | 28.53% | 120/157 | 20.99% | 迈威生物 | 99.67% | 行业排名> |
| 2021-12-31 | 22.21% | 2.89% | -9.2% | 140/157 | 55.2% | 迈威生物 | 99.44% | 行业排名> |
| 2021-09-30 | 24.46% | 2% | 6.36% | 121/157 | 46.77% | 迈威生物 | 98.57% | 行业排名> |
| 2021-03-31 | 23% | 2% | 6.53% | 114/157 | 54.13% | 首药控股 | 99.93% | 行业排名> |
| 2020-12-31 | 21.59% | 1.71% | 1.71% | 136/157 | -148.64% | 艾力斯 | 99.41% | 行业排名> |
| 2019-12-31 | 21.23% | -15.09% | -15.09% | 128/157 | -1242.15% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | 25% | 2% | 2% | 121/157 | -211.97% | 艾力斯 | 99.4% | 行业排名> |